Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,265
archived clinical trials in
Rheumatoid Arthritis

BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
STAT Research, Incorporated
mi
from
Dayton, OH
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
STAT Research, Incorporated
mi
from
Dayton, OH
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Clinical Research Source, Inc.
mi
from
Perrysburg, OH
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Clinical Research Source, Inc.
mi
from
Perrysburg, OH
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Altoona Center for Clinical Research
mi
from
Duncansville, PA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Mountain View Clinical Research
mi
from
Greer, SC
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Mountain View Clinical Research
mi
from
Greer, SC
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Center For Inflammatory Disease
mi
from
Nashville, TN
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Center For Inflammatory Disease
mi
from
Nashville, TN
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Austin Regional Clinic
mi
from
Austin, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Austin Regional Clinic
mi
from
Austin, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Adriana Pop-Moody MD - Clinic PA
mi
from
Corpus Christi, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Adriana Pop-Moody MD - Clinic PA
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Metroplex Clinical Research Center
mi
from
Dallas, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Metroplex Clinical Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Accurate Clinical Management
mi
from
Houston, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Accurate Clinical Management
mi
from
Houston, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Accurate Clinical Research, Incorporated
mi
from
Houston, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Accurate Clinical Research, Incorporated
mi
from
Houston, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Rheumatology Clinic of Houston
mi
from
Houston, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Rheumatology Clinic of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Houston Rheumatology Consultants
mi
from
Houston, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Houston Rheumatology Consultants
mi
from
Houston, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Arthritis & Osteoporosis Associates LLP
mi
from
Lubbock, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Arthritis & Osteoporosis Associates LLP
mi
from
Lubbock, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Accurate Clinical Research, Incorporated
mi
from
Nassau Bay, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Accurate Clinical Research, Incorporated
mi
from
Nassau Bay, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Heartland Research Associates, LLC
mi
from
San Antonio, TX
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Heartland Research Associates, LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Danville Orthopedic Clinic, Incorporated
mi
from
Danville, VA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Danville Orthopedic Clinic, Incorporated
mi
from
Danville, VA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Arthritis Northwest
mi
from
Spokane, WA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Arthritis Northwest
mi
from
Spokane, WA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
MHAT "Trimontium", OOD, Plovdiv
mi
from
Plovdiv,
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
MHAT "Trimontium", OOD, Plovdiv
mi
from
Plovdiv,
Click here to add this to my saved trials
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  12/22/2017
Clinical Research Facility
mi
from
Aventura, FL
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 12/22/2017
Clinical Research Facility
mi
from
Aventura, FL
Click here to add this to my saved trials
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  12/22/2017
Clinical Research Facility
mi
from
Lexington, KY
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 12/22/2017
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  12/22/2017
Clinical Research Facility
mi
from
Frederick, MD
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 12/22/2017
Clinical Research Facility
mi
from
Frederick, MD
Click here to add this to my saved trials
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  12/22/2017
Clinical Research Facility
mi
from
Kalamazoo, MI
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 12/22/2017
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  12/22/2017
Clinical Research Facility
mi
from
Charlotte, NC
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 12/22/2017
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  12/22/2017
Clinical Research Facility
mi
from
Duncansville, PA
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 12/22/2017
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  12/22/2017
Clinical Research Facility
mi
from
Anderson, SC
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 12/22/2017
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  12/22/2017
mi
from
Budapest,
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 12/22/2017
mi
from
Budapest,
Click here to add this to my saved trials
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated:  12/22/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status: Enrolling
Updated: 12/22/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Rheumatology Associates, PC
mi
from
Birmingham, AL
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Rheumatology Associates, PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Achieve Clinical Research
mi
from
Birmingham, AL
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Arizona Arthritis & Rheumatology Associates, P.C.
mi
from
Glendale, AZ
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Arizona Arthritis & Rheumatology Associates, P.C.
mi
from
Glendale, AZ
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Arizona Arthritis & Rheumatology Research, PLLC
mi
from
Mesa, AZ
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Arizona Arthritis & Rheumatology Research, PLLC
mi
from
Mesa, AZ
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Arizona Arthritis & Rheumatology Research PLLC
mi
from
Phoenix, AZ
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Arizona Arthritis & Rheumatology Research PLLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Little Rock Diagnostic Clinic
mi
from
Little Rock, AR
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Little Rock Diagnostic Clinic
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Medvin Clinical Research
mi
from
Covina, CA
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Medvin Clinical Research
mi
from
Covina, CA
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
TriWest Research Associates, LLC
mi
from
El Cajon, CA
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
TriWest Research Associates, LLC
mi
from
El Cajon, CA
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Advanced Medical Research, LLC
mi
from
Lakewood, CA
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Advanced Medical Research, LLC
mi
from
Lakewood, CA
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Premiere Clinical Research
mi
from
Lakewood, CA
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Premiere Clinical Research
mi
from
Lakewood, CA
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
ProHealth Partners
mi
from
Long Beach, CA
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
ProHealth Partners
mi
from
Long Beach, CA
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
San Diego Arthritis Medical Clinic
mi
from
San Diego, CA
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
San Diego Arthritis Medical Clinic
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Arthritis Center Medical Group
mi
from
Santa Maria, CA
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Arthritis Center Medical Group
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Westlake Medical Research
mi
from
Thousand Oaks, CA
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Westlake Medical Research
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Inland Rheumatology Clinical Trials, Inc.
mi
from
Upland, CA
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Inland Rheumatology Clinical Trials, Inc.
mi
from
Upland, CA
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Nascimento, Joao (Private Practice)
mi
from
Bridgeport, CT
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Nascimento, Joao (Private Practice)
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Avail Clinical Research
mi
from
DeLand, FL
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
New Horizon Research Center
mi
from
Miami, FL
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
New Horizon Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Arthritis Associates
mi
from
Orlando, FL
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Arthritis Associates
mi
from
Orlando, FL
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Family Clinical Trials, Incorporated
mi
from
Pembroke Pines, FL
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Family Clinical Trials, Incorporated
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated:  1/4/2018
Arthritis & Rheumatology Associates of Palm Beach
mi
from
Tampa, FL
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
Status: Enrolling
Updated: 1/4/2018
Arthritis & Rheumatology Associates of Palm Beach
mi
from
Tampa, FL
Click here to add this to my saved trials